Adipose tissue inflammation: A cause or consequence of obesity-related insulin resistance?

Clinical Science

Volumn 130, Issue 18, 2016, Pages 1603-1614

  Blüher, Matthias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adipocytes; Adipokines; Adipose tissue inflammation; Adipose tissue macrophages; Insulin resistance; Obesity

Indexed keywords

ACETYLCYSTEINE; ADIPOCYTOKINE; ADIPONECTIN; ANAKINRA; ANTIINFLAMMATORY AGENT; CANAKINUMAB; CHEMOKINE; CRYOPYRIN; CYTOKINE; CYTOKINE RECEPTOR; ETANERCEPT; GEVOKIZUMAB; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; LENERCEPT; LEPTIN; LY 2189102; SALSALATE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; B LYMPHOCYTE; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CELL STRESS; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DIABETOGENESIS; DYSLIPIDEMIA; ENERGY BALANCE; EPIDEMIC; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; LIPOTOXICITY; MACROPHAGE; MALIGNANT NEOPLASM; METABOLIC DISORDER; MONOCYTE; MORBID OBESITY; MORTALITY; MUSCULOSKELETAL DISEASE; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SLEEVE GASTRECTOMY; T LYMPHOCYTE; TRANSGENIC ANIMAL; WEIGHT GAIN; ANIMAL; IMMUNOLOGY; METABOLISM;

ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; INSULIN RESISTANCE; OBESITY;

EID: 85014373529     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160005     Document Type: Article

References (106)

1. Hotamisligil, G.S. (2006) Inflammation and metabolic disorders. Nature 444, 860-867.
2. Shoelson, S.E., Lee, J. and Goldfine, A.B. (2006) Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801.
3. Ebstein, W. (1876) Zur Therapie des Diabetes mellitus, insbesondere über die Anwendung des salicylsauren Natron bei demselben. Berlöiner Klinische Wochenschrift 13, 337-340
4. Schmidt, M.I., Duncan, B.B., Sharrett, A.R., Lindberg, G., Savage, P.J., Offenbacher, S., Azambuja, M.I., Tracy, R.P. and Heiss, G. (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353, 1649-1652.
5. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E. and Ridker, P.M. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334.
6. Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M.M., Ristow, M., Boeing, H. and Pfeiffer, A.F. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812-817.
7. Ford, E.S. (2002) Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am. J. Epidemiol. 155, 57-64.
8. Herder, C., Carstensen, M. and Ouwens, D.M. (2013) Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes. Metab. 15 Suppl. 3, 39-50.
9. Herder, C., Nuotio, M.L., Shah, S., Blankenberg, S., Brunner, E.J., Carstensen, M., Gieger, C., Grallert, H., Jula, A., Kähönen, M. et al. (2014) Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits. Diabetes 63, 4343-4359.
10. Haffner, S., Temprosa, M., Crandall, J., Fowler, S., Goldberg, R., Horton, E., Marcovina, S., Mather, K., Orchard, T., Ratner, R., Barrett-Connor, E., Diabetes Prevention Program Research Group (2005) Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 54, 1566-1572.
11. Gumbau, V., Bruna, M., Canelles, E., Guaita, M., Mulas, C., Basés, C., Celma, I., Puche, J., Marcaida, G., Oviedo, M. and Vázquez, A. (2014) A prospective study on inflammatory parameters in obese patients after sleeve gastrectomy. Obes. Surg. 24, 903-908.
12. Oberbach, A., Tönjes, A., Klöting, N., Fasshauer, M., Kratzsch, J., Busse, M.W., Paschke, R., Stumvoll, M. and Blüher, M. (2006) Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur. J. Endocrinol. 154, 577-585.
13. Goldfine, A.B., Fonseca, V., Jablonski, K.A., Chen, Y.D., Tipton, L., Staten, M.A., Shoelson, S.E., Targeting Inflammation Using Salsalate in Type 2 Diabetes Study Team (2013) Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 159, 1-12.
14. Hotamisligil, G.S., Shargill, N.S. and Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
15. Blüher, M. (2013) Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract. Res. Clin. Endocrinol. Metab. 27, 163-177.
16. Colditz, G.A., Willett, W.C., Rotnitzky, A. and Manson, J.E. (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med. 122, 481-486.
17. Moitra, J., Mason, M.M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M. et al. (1998) Life without white fat: a transgenic mouse. Genes Dev 12, 3168-3181.
18. Burant, C.F., Sreenan, S., Hirano, K., Tai, T.A., Lohmiller, J., Lukens, J., Davidson, N.O., Ross, S. and Graves, R.A. (1997) Troglitazone action is independent of adipose tissue. J. Clin. Invest. 100, 2900-2908.
19. Robbins, A.L. and Savage, D.B. (2015) The genetics of lipid storage and human lipodystrophies. Trends Mol. Med. 21, 433-438.
20. Konrad, D., Rudich, A. and Schoenle, E.J. (2007) Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue. Diabetologia 50, 833-839.
21. Tran, T.T., Yamamoto, Y., Gesta, S. and Kahn, C.R. (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7, 410-420.
22. Cinti, S. (2012) The adipose organ at a glance. Dis. Model Mech. 5, 588-594.
23. Cohen, P. and Spiegelman, B.M. (2015) Brown and Beige fat: molecular parts of a thermogenic machine. Diabetes 64, 2346-2351.
24. Waldén, T.B., Hansen, I.R., Timmons, J.A., Cannon, B. and Nedergaard, J. (2012) Recruited vs. nonrecruited molecular signatures of brown, "brite," and white adipose tissues. Am. J. Physiol. Endocrinol. Metab. 302, E19-E31.
25. van Marken Lichtenbelt, W.D., Vanhommerig, J.W., Smulders, N.M., Drossaerts, J.M., Kemerink, G.J., Bouvy, N.D., Schrauwen, P. and Teule, G.J. (2009) Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508.
26. Cypess, A.M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A.B., Kuo, F.C., Palmer, E.L., Tseng, Y.H., Doria, A. et al. (2009) Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509-1517.
27. Spalding, K.L., Arner, E., Westermark, P.O., Bernard, S., Buchholz, B.A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T. et al. (2008) Dynamics of fat cell turnover in humans. Nature 453, 783-787.
28. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante, Jr, A.W. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808.
29. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S. and Obin, M.S. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355.
30. Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., Coupaye, M., Pelloux, V., Hugol, D., Bouillot, J.L. et al. (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 2277-2286.
31. Harman-Boehm, I., Blüher, M., Redel, H., Sion-Vardy, N., Ovadia, S., Avinoach, E., Shai, I., Klöting, N., Stumvoll, M., Bashan, N. and Rudich, A. (2007) Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J. Clin. Endocrinol. Metab. 92, 2240-2247.
32. Schmitz, J., Evers, N., Awazawa, M., Nicholls, H.T., Brönneke, H.S., Dietrich, A., Mauer, J., Blüher, M. and Brüning, J.C. (2016) Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss. Mol. Metab. 5, 328-339.
33. Sell, H., Habich, C. and Eckel, J. (2012) Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol. 8, 709-716.
34. Kintscher, U., Hartge, M., Hess, K., Foryst-Ludwig, A., Clemenz, M., Wabitsch, M., Fischer-Posovszky, P., Barth, T.F., Dragun, D., Skurk, T. et al. (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler. Thromb. Vasc. Biol. 28, 1304-1310.
35. Klöting, N., Fasshauer, M., Dietrich, A., Kovacs, P., Schön, M.R., Kern, M., Stumvoll, M. and Blüher, M. (2010) Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 299, E506-E515.
36. Hardy, O.T., Perugini, R.A., Nicoloro, S.M., Gallagher-Dorval, K., Puri, V., Straubhaar, J. and Czech, M.P. (2011) Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity. Surg. Obes. Relat. Dis. 7, 60-67.
37. Landgraf, K., Rockstroh, D., Wagner, I.V., Weise, S., Tauscher, R., Schwartze, J.T., Löffler, D., Bühligen, U., Wojan, M., Till, H. et al. (2015) Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children. Diabetes 64, 1249-1261.
38. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A. and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830.
39. Herrero, L., Shapiro, H., Nayer, A., Lee, J. and Shoelson, S.E. (2010) Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc. Natl. Acad. Sci. U.S.A. 107, 240-245.
40. Donath, M.Y. (2014) Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat. Rev. Drug Discov. 13, 465-476.
41. Blüher, M. (2009) Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes 117, 241-250.
42. Blüher, M., Bashan, N., Shai, I., Harman-Boehm, I., Tarnovscki, T., Avinaoch, E., Stumvoll, M., Dietrich, A., Klöting, N. and Rudich, A. (2009) Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body Insulin sensitivity. J. Clin. Endocrinol. Metab. 94, 2507-2515.
43. Haase, J., Weyer, U., Immig, K., Klöting, N., Blüher, M., Eilers, J., Bechmann, I. and Gericke, M. (2014) Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia 57, 562-571.
44. Salans, L.B., Knittle, J.L. and Hirsch, J. (1968) The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J. Clin. Invest. 47, 153-165.
45. Stern, J.S., Batchelor, B.R., Hollander, N., Cohn, C.K. and Hirsch, J. (1972) Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet 2, 948-951.
46. Skurk, T., Alberti-Huber, C., Herder, C. and Hauner, H. (2007) Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 92, 1023-1033.
47. Laurencikiene, J., Skurk, T., Kulyté, A., Hedén, P., Aström, G., Sjölin, E., Rydén, M., Hauner, H. and Arner, P. (2011) Regulation of lipolysis in small and large fat cells of the same subject. J. Clin. Endocrinol. Metab. 96, E2045-E2049.
48. Cotillard, A., Poitou, C., Torcivia, A., Bouillot, J.L., Dietrich, A., Klöting, N., Grégoire, C., Lolmede, K., Blüher, M. and Clément, K. (2014) Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J. Clin. Endocrinol. Metab. 99, E1466-E1470.
49. Kosacka, J., Kern, M., Klöting, N., Paeschke, S., Rudich, A., Haim, Y., Gericke, M., Serke, H., Stumvoll, M., Bechmann, I. et al. (2015) Autophagy in adipose tissue of patients with obesity and type 2 diabetes. Mol. Cell. Endocrinol. 409, 21-32.
50. Haim, Y., Blüher, M., Slutsky, N., Goldstein, N., Klöting, N., Harman-Boehm, I., Kirshtein, B., Ginsberg, D., Gericke, M., Guiu Jurado, E. et al. (2015) Elevated autophagy gene expression in adipose tissue of obese humans: a potential non-cell-cycle-dependent function of E2F1. Autophagy 11, 2074-2088.
51. Arner, E., Westermark, P.O., Spalding, K.L., Britton, T., Rydén, M., Frisén, J., Bernard, S. and Arner, P. (2010) Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59, 105-109.
52. Gealekman, O., Guseva, N., Hartigan, C., Apotheker, S., Gorgoglione, M., Gurav, K., Tran, K.V., Straubhaar, J., Nicoloro, S., Czech, M.P. et al. (2011) Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 123, 186-194.
53. Van Harmelen, V., Röhrig, K. and Hauner, H. (2004) Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 53, 632-637.
54. Blüher, M., Michael, M.D., Peroni, O.D., Ueki, K., Carter, N., Kahn, B.B. and Kahn, C.R. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3, 25-38.
55. Mauer, J., Chaurasia, B., Plum, L., Quast, T., Hampel, B., Blüher, M., Kolanus, W., Kahn, C.R. and Brüning, J.C. (2010) Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet 6, e1000938.
56. Trayhurn, P. (2013) Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev. 93, 1-21.
57. Kihira, Y., Miyake, M., Hirata, M., Hoshina, Y., Kato, K., Shirakawa, H., Sakaue, H., Yamano, N., Izawa-Ishizawa, Y., Ishizawa, K. et al. (2014) Deletion of hypoxia-inducible factor-1a in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation. PLoS One 9, e93856.
58. Choe, S.S., Shin, K.C., Ka, S., Lee, Y.K., Chun, J.S. and Kim, J.B. (2014) Macrophage HIF-2a ameliorates adipose tissue inflammation and insulin resistance in obesity. Diabetes 63, 3359-3371.
59. Rudich, A., Kanety, H. and Bashan, N. (2007) Adipose stress-sensing kinases: linking obesity to malfunction. Trends Endocrinol. Metab. 18, 291-299.
60. Nishimoto, S., Fukuda, D., Higashikuni, Y., Tanaka, K., Hirata, Y., Murata, C., Kim-Kaneyama, J.R., Sato, F., Bando, M., Yagi, S. et al. (2016) Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Sci. Adv. 2, e1501332.
61. Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J.Y., Ko, H.J., Barrett, T., Kim, J.K. and Davis, R.J. (2008) A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539-1543.
62. Han, M.S., Jung, D.Y., Morel, C., Lakhani, S.A., Kim, J.K., Flavell, R.A. and Davis, R.J. (2013) JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339, 218-222.
63. Bierhaus, A., Humpert, P.M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D.M. and Nawroth, P.P. (2005) Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. (Berl) 83, 876-886.
64. Fink, M.P. (1990) Leaky gut hypothesis: a historical perspective. Crit. Care Med. 18, 579-580.
65. Vandanmagsar, B., Youm, Y.H., Ravussin, A., Galgani, J.E., Stadler, K., Mynatt, R.L., Ravussin, E., Stephens, J.M. and Dixit, V.D. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188.
66. Stienstra, R. and Stefan, N. (2013) Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. Diabetologia 56, 2343-2346.
67. Grimsrud, P.A., Picklo, Sr, M.J., Griffin, T.J. and Bernlohr, D.A. (2007) Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell. Proteomics 6, 624-637.
68. Lin, Y., Berg, A.H., Iyengar, P., Lam, T.K., Giacca, A., Combs, T.P., Rajala, M.W., Du, X., Rollman, B., Li, W. et al. (2005) The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 280, 4617-4626.
69. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A.H., Iwakoshi, N.N., Ozdelen, E., Tuncman, G., Görgün, C., Glimcher, L.H. and Hotamisligil, G.S. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461.
70. Kawasaki, N., Asada, R., Saito, A., Kanemoto, S. and Imaizumi, K. (2012) Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue. Sci. Rep. 2, 799.
71. Kang, S., Dahl, R., Hsieh, W., Shin, A., Zsebo, K.M., Buettner, C., Hajjar, R.J. and Lebeche, D. (2016) Small molecular allosteric activator of the Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) attenuates diabetes and metabolic disorders. J. Biol. Chem. 291, 5185-5198.
72. Tard, C., Rouxel, O. and Lehuen, A. (2015) Regulatory role of natural killer T cells in diabetes. Biomed. J. 38, 484-495.
73. Lee, B.C., Kim, M.S., Pae, M., Yamamoto, Y., Eberlé, D., Shimada, T., Kamei, N., Park, H.S., Sasorith, S., Woo, J.R. et al. (2016) Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity. Cell Metab 23, 685-698.
74. Chatzigeorgiou, A. and Chavakis, T. (2016) Immune cells and metabolism. Handb. Exp. Pharmacol. 233, 221-249.
75. Ferrante, Jr, A.W. (2013) The immune cells in adipose tissue. Diabetes Obes. Metab. 15 (Suppl. 3), 34-38.
76. Grant, R.W. and Dixit, V.D. (2015) Adipose tissue as an immunological organ. Obesity (Silver Spring) 23, 512-518.
77. Divoux, A., Moutel, S., Poitou, C., Lacasa, D., Veyrie, N., Aissat, A., Arock, M., Guerre-Millo, M. and Clément, K. (2012) Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J. Clin. Endocrinol. Metab. 97, E1677-E1685.
78. Liu, J., Divoux, A., Sun, J., Zhang, J., Clément, K., Glickman, J.N., Sukhova, G.K., Wolters, P.J., Du, J., Gorgun, C.Z. et al. (2009) Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 15, 940-945.
79. Shapiro, H., Pecht, T., Shaco-Levy, R., Harman-Boehm, I., Kirshtein, B., Kuperman, Y., Chen, A., Blüher, M., Shai, I. and Rudich, A. (2013) Adipose tissue foam cells are present in human obesity. J. Clin. Endocrinol. Metab. 98, 1173-1181.
80. Stienstra, R., Haim, Y., Riahi, Y., Netea, M., Rudich, A. and Leibowitz, G. (2014) Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes. Diabetologia 57, 1505-1516.
81. Kovsan, J., Blüher, M., Tarnovscki, T., Klöting, N., Kirshtein, B., Madar, L., Shai, I., Golan, R., Harman-Boehm, I., Schön, M.R. et al. (2011) Altered autophagy in human adipose tissues in obesity. J. Clin. Endocrinol. Metab. 96, E268-E277.
82. Soussi, H., Clément, K. and Dugail, I. (2016) Adipose tissue autophagy status in obesity: expression and flux-two faces of the picture. Autophagy 12, 588-589.
83. Keuper, M., Blüher, M., Schön, M.R., Möller, P., Dzyakanchuk, A., Amrein, K., Debatin, K.M., Wabitsch, M. and Fischer-Posovszky, P. (2011) An inflammatory micro-environment promotes human adipocyte apoptosis. Mol. Cell. Endocrinol. 339, 105-113.
84. Blüher, M., Klöting, N., Wueest, S., Schoenle, E.J., Schön, M.R., Dietrich, A., Fasshauer, M., Stumvoll, M. and Konrad, D. (2014) Fas and FasL expression in human adipose tissue is related to obesity, insulin resistance, and type 2 diabetes. J. Clin. Endocrinol. Metab. 99, E36-E44.
85. Alkhouri, N., Gornicka, A., Berk, M.P., Thapaliya, S., Dixon, L.J., Kashyap, S., Schauer, P.R. and Feldstein, A.E. (2010) Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J. Biol. Chem. 285, 3428-3438.
86. Wueest, S., Rapold, R.A., Schumann, D.M., Rytka, J.M., Schildknecht, A., Nov, O., Chervonsky, A.V., Rudich, A., Schoenle, E.J., Donath, M.Y. and Konrad, D. (2010) Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J. Clin. Invest. 120, 191-202.
87. Wueest, S., Rapold, R.A., Schoenle, E.J. and Konrad, D. (2010) Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt. FEBS Lett 584, 4187-4192.
88. Rapold, R.A., Wueest, S., Knoepfel, A., Schoenle, E.J. and Konrad, D. (2013) Fas activates lipolysis in a Ca2+-CaMKII-dependent manner in 3T3-L1 adipocytes. J. Lipid Res. 54, 63-70.
89. Prentki, M., Matschinsky, F.M. and Madiraju, S.R. (2013) Metabolic signaling in fuel-induced insulin secretion. Cell Metab 18, 162-185.
90. Abel, E.D., Peroni, O., Kim, J.K., Kim, Y.B., Boss, O., Hadro, E., Minnemann, T., Shulman, G.I. and Kahn, B.B. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729-733.
91. Brunzell, J.D., Robertson, R.P., Lerner, R.L., Hazzard, W.R., Ensinck, J.W., Bierman, E.L. and Porte, Jr, D. (1976) Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J. Clin. Endocrinol. Metab. 42, 222-229.
92. Fasshauer, M. and Blüher, M. (2015) Adipokines in health and disease. Trends Pharmacol. Sci. 36, 461-470.
93. Dahlman, I., Elsen, M., Tennagels, N., Korn, M., Brockmann, B., Sell, H., Eckel, J. and Arner, P. (2012) Functional annotation of the human fat cell secretome. Arch. Physiol. Biochem. 118, 184-191.
94. Lehr, S., Hartwig, S. and Sell, H. (2012) Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin. Appl. 6, 91-101.
95. Blüher, M. (2014) Adipokines-removing road blocks to obesity and diabetes therapy. Mol. Metab. 3, 230-240.
96. Gaich, G., Chien, J.Y., Fu, H., Glass, L.C., Deeg, M.A., Holland, W.L., Kharitonenkov, A., Bumol, T., Schilske, H.K. and Moller, D.E. (2013) The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab 18, 333-340.
97. Larsen, C.M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J.A., Seifert, B., Mandrup-Poulsen, T. and Donath, M.Y. (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517-1526.
98. Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R.L. and Ferrante, Jr, A.W. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124.
99. Youn, B.S., Bang, S.I., Klöting, N., Park, J.W., Lee, N., Oh, J.E., Pi, K.B., Lee, T.H., Ruschke, K., Fasshauer, M. et al. (2009) Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes 58, 627-636.
100. Chakaroun, R., Raschpichler, M., Klöting, N., Oberbach, A., Flehmig, G., Kern, M., Schön, M.R., Shang, E., Lohmann, T., Dreßler, M. et al. (2012) Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 61, 706-714.
101. Moraes-Vieira, P.M., Yore, M.M., Dwyer, P.M., Syed, I., Aryal, P. and Kahn, B.B. (2014) RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab 19, 512-526.
102. Scherer, P.E. (2014) Adiponectin: basic and clinical aspects. Preface. Best. Pract. Res. Clin. Endocrinol. Metab. 28, 1-2.
103. Dalmas, E., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron-Wisnewsky, J., Lacroix-Desmazes, S., Bayry, J., Kaveri, S.V., Clément, K. et al. (2014) T cell-derived IL-22 amplifies IL-1ß-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes 63, 1966-1977.
104. Herder, C. and Donath, M.Y. (2015) Interleukin-1 receptor antagonist: friend or foe to the heart? Lancet Diabetes Endocrinol. 3, 228-229
105. Zhou, L., Park, S.Y., Xu, L., Xia, X., Ye, J., Su, L., Jeong, K.H., Hur, J.H., Oh, H., Tamori, Y. et al. (2015) Insulin resistance and white adipose tissue inflammation are uncoupled in energetically challenged Fsp27-deficient mice. Nat. Commun. 6, 5949.
106. Wernstedt Asterholm, I., Tao, C., Morley, T.S., Wang, Q.A., Delgado-Lopez, F., Wang, Z.V. and Scherer, P.E. (2014) Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 20, 103-118.